Training and Continuing Education
Nov. 7-9 2011 Course - Videos, Slides, Transcripts
Monday, November 7, 2011
Video: Morning Session https://collaboration.fda.gov/p52033364/ Slides: Morning Session 8:30 - 9:00 a.m.
FDA Structure and Mandate (PDF - 1MB)
9:00 - 9:45 a.m.
Good Clinical Practice - Key Topics (PDF - 79KB)
9:45 - 11:00 a.m.
Investigator Responsibilities - Parts 1 and 2 (PDF - 1MB)
11:00 - 11:45 a.m.
Informed Consent and Ethical Considerations (PPT)
Video: Afternoon Session
https://collaboration.fda.gov/p25725932/
Slides: Afternoon Session
1:00-1:30 p.m. CMC and the Investigator Brochure (Drugs) (PDF - 180KB)
1:30-2:00 p.m. CMC and the Investigator Brochure (Biologics) (PDF - 63KB)
2:00-2:45 p.m. Pharmacology/Toxicology in the Investigator Brochure (PDF - 157KB)
3:15-4:00 p.m. Clinical Pharmacology 1 (PDF - 263KB)
4:00-4:45 p.m. Clinical Pharmacology 2 (PDF - 473KB)
Tuesday, November 8, 2011
https://collaboration.fda.gov/p86158174/ Slides: Morning Session Video: Morning Session
8:30- 9:00 a.m.
FDA Perspective on International Studies (PDF - 596KB)
9:00-10:45 a.m.
The Design of Clinical Trials (Parts I and II) (PDF - 1MB)
11:00-11:30 a.m.
Clinical Trial Endpoints (PDF - 99KB)
11:30-12:00 p.m.
Issues in Clinical Trial Designs for Devices (PDF - 287KB)
Video: Afternoon Session
https://collaboration.fda.gov/p45318823/
Slides: Afternoon Session
1:00-1:30 p.m. Issues in Clinical Trial Design (PDF - 294KB)
1:30-2:15 p.m. The Analysis of Investigator Data, Sources of Bias and Error (PDF - 1MB)
2:45-3:15 p.m. Safety Considerations in Phase 1 Trials (PDF - 99KB)
3:15-3:45 p.m. Safety Assessment in Clinical Trials and Beyond (PPT)
3:45-4:15 p.m. Clinical Discussion of Special Populations (PDF - 486KB)
Wednesday, November 9, 2011
8:30-10:00 a.m. 8:30-10:00 a.m. Slides: Morning Session
How to put together an application (Milstein) (CDER) (PDF - 255KB)
How to put together an application
(Purohit-Sheth) (PDF - 263KB)
8:30-10:00 a.m.
How to put together an application (Fink) (CBER) (PDF - 204KB)
How to put together an application (Au) (CBER) (PDF - 204KB)
How to put together an application (Witten) (CBER) (PDF - 433KB)
How to put together an application (Marcarelli) (CDRH)
How to put together an application (Henley) (CDRH) (PDF - 858KB)
Slides: Morning Session (cont)
10:15-11:15 a.m. Ensuring the Safety of Clinical Trials (PDF - 111KB): AE Reporting, DSMBs, IRBs (CDER)
10:15-11:15 a.m. Ensuring the Safety of Clinical Trials: AE Reporting, DSMBs, IRBs (CBER)
10:15-11:15 a.m. Ensuring the Safety of Clinical Trials: AE Reporting, DSMBs, IRBs (CDRH)
Video: Afternoon Session
https://collaboration.fda.gov/p97371694/
Slides: Afternoon Session
12:45-1:15 p.m. Special cardiac safety issues: QT prolongation and valvulopathy (PDF - 297KB)
1:15-1:45 p.m. Drug-Induced Liver Injury (DILI) (PDF - 399KB)
1:45-2:15 p.m. A patient advocate's perspective on clinical trials (PDF - 108KB)
2:15-3:15 p.m. Roundtable (PDF - 234KB)